Navigation Links
Micromet Announces Definitive Agreement for $40 Million Private Equity Placement
Date:9/30/2008

Funding Proceeds to Support R&D Efforts and Clinical Trials Advancing the BiTE Therapeutic Antibody Platform

BETHESDA, Md., Sept. 30 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI) ("Micromet" or the "Company"), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it has entered into a definitive agreement with various institutional investors to raise $40 million in a private placement of its common stock and warrants.

Under the terms of the definitive agreement, Micromet is expected to sell approximately 9.4 million shares of common stock and warrants to purchase approximately 2.8 million shares of common stock at a total purchase price of $4.25 per unit, with each unit consisting of one share of common stock and a warrant to purchase 0.30 shares of common stock. The warrants are exercisable at $4.63 per share and will expire five years after the date of grant. The closing of the transaction, which is expected to occur on or about October 2, 2008, is subject to customary closing conditions. Piper Jaffray & Co. served as sole bookrunning lead placement agent, with RBC Capital Markets acting as co-lead placement agent, and Natixis Bleichroeder serving as financial advisor on the offering.

The net proceeds of the financing will be used for continued research and development of Micromet's product candidates and operational expenses including the advancement of clinical trials for the company's lead BiTE antibody blinatumomab (MT103/MEDI-538).

This news release is not an offer to sell or the solicitation of an offer to buy the securities discussed herein. These securities have not been registered under th
'/>"/>

SOURCE Micromet, Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule
2. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
3. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
4. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
5. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
6. Micromet to Present at Two Upcoming Investor Conferences
7. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
8. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
9. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
10. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
11. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... ReliantHeart, Inc., an innovative supplier of advanced mechanical ... transit-time flow measurement solutions, are collaborating on a miniature ... the HeartAssist5® Left Ventricular Assist Device (LVAD). ... and peace of mind. , The Transonic flow ... 1/6th of the power required by earlier flow board ...
(Date:3/25/2015)... 26, 2015 Agnition announced today that ... American Farmer, airing for the first time at 7:30 ... American Farmer will explore the extremely important role soil ... with a patented Microbial Catalyst™ technology that enhances soil ... The segment will air again on April 28. , ...
(Date:3/25/2015)... (PRWEB) March 25, 2015 Laboratory ... Top-Loading Balances and Analytical Balances to get best-performing ... line of weighing balances from the trusted brand ... Balances increase your efficiency by providing a ... of samples. Weighing modes include parts counting, percent ...
(Date:3/25/2015)... Francisco, CA (PRWEB) March 25, 2015 ... Support for Novel Mechanism of Action in Neuromuscular ... 25, 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... fast skeletal muscle troponin activator tirasemtiv in the ... a Phase IIa “Evidence of Effect” or hypothesis-generating ...
Breaking Biology Technology:LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2New Economical Top-Loading and Analytical Symmetry Balances from Cole-Parmer 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
... Inc. (OTC Bulletin Board: YGYB; "Yongye" or the ... products located in the,People,s Republic of China, today ... March 31, 2009. The Company expects net revenue ... from $12.0 million to $12.5 million, up,approximately 26% ...
... 21 Bio-Matrix Scientific Group, Inc. (OTC Bulletin Board: ... announced today that its Board of Directors has declared ... record as of May 5th, 2009 to be paid ... Common shareholders will be entitled to receive one share ...
... has been named the,Singapore Entrepreneurial Company of the ... that have pushed the boundaries of excellence in ... 2008.,Mr David Picard, CEO of Moleac, received the ... Award for Singapore Entrepreneurial Company,of the Year at ...
Cached Biology Technology:Yongye Biotechnology Announces Preliminary Results for its Fiscal Quarter Ended March 31, 2009 2Yongye Biotechnology Announces Preliminary Results for its Fiscal Quarter Ended March 31, 2009 3Bio-Matrix Scientific Group, Inc. Announces Preferred Stock Dividend and Spinoff of Wholly-Owned Subsidiary, Entest Biomedical, Inc. 2Bio-Matrix Scientific Group, Inc. Announces Preferred Stock Dividend and Spinoff of Wholly-Owned Subsidiary, Entest Biomedical, Inc. 3Moleac Named Singapore Entrepreneurial Company of the Year at the Frost & Sullivan Excellence in Healthcare Awards 2Moleac Named Singapore Entrepreneurial Company of the Year at the Frost & Sullivan Excellence in Healthcare Awards 3
(Date:3/12/2015)... 12, 2015 Beta Systems ... and access management (IAM) solution for a fixed ... Beta System,s new IAM package, customers benefit from ... from multiple IAM implementations across different industries. The ... well as any necessary services and consulting. It ...
(Date:3/11/2015)... Mar. 11, 2015 Research and Markets ... "Access Control Market by Product, Application & By ... report to their offering. , This report ... reach $10.4 billion by 2020, with an estimated CAGR ... covers the products types such as contact cards & ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
... The first evidence of cardiac progenitor cells ?rare, specialized ... mice and humans ?has been shown by researchers at ... Medicine. The cells are capable of differentiation into fully ... progenitor cells are stem cells that have been programmed ...
... The human mouth teems with millions of enamel-eroding, gum-inflaming ... bacterial homesteader that stakes a claim deep within the ... cause of tooth loss ?secreting proteins that destroy the ... periodontal disease. , Now scientists have identified the thousands ...
... genes we have in our genome—more than a fruitfly, ... has often been obscured. The expression of 20,000?0,000 genes ... non-coding sequences, which bind transcription factors and thereby regulate ... whose signatures are easy to spot, the characteristic features ...
Cached Biology News:UCSD team discovers specialized, rare heart stem cells in newborns 2UCSD team discovers specialized, rare heart stem cells in newborns 3UF Researchers Map Bacterial Proteins That Cause Tooth Loss 2UF Researchers Map Bacterial Proteins That Cause Tooth Loss 3Unexpressed But Indispensable -- The DNA Sequences That Control Development 2
... Lipid adsorption and clarification reagent; ... the purification of antibodies, proteins, nucleic ... has negligible cross-reactivity, and improves downstream ... a solid-phase, non-ionic adsorbent supplied as ...
A simple, sensitive and reliable method for determining free sulfhydryl content in peptides, protein...
... incubator-shaker, has the smallest footprint of all our ... x 680 mm (W x D) does not ... x 510mm). Available in 25 mm or 50 ... shaking applications requiring controlled speed and temperature ...
Request Info...
Biology Products: